Saroja Pharma Industries India Limited (NSE: SAROJA) is a Mumbai, Maharashtra-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹15 Cr, it ranks #4,580 by market cap among the 6,197 Indian listed companies on FinBizNet, and #11 of 13 in Pharmaceutical Product Distribution. At ₹38.00 (as of 16 Nov 2026), the share price is 12.1% below its 52-week high of ₹43.25 and 35.7% above its 52-week low of ₹28.00. The share price is down 11.9% over one year and up 20.8% over three months.
| Current Price | ₹38.00 |
|---|---|
| Market Cap | ₹15 Cr |
| NSE Symbol | SAROJA |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 9.5 |
| Return on Equity | 9.83% |
| Return on Assets | 5.71% |
| 52-Week Range | ₹28.00 – ₹43.25 |
| 1-Year Price Change | -11.9% |
| 3-Month Price Change | +20.8% |
| Beta (1Y) | 0.21 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.sarojapharma.com |
Promoters held 73.02% of Saroja Pharma Industries India Limited's shares as of Mar 2026, unchanged from Mar 2025.
Saroja Pharma Industries India Limited trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, Europe, and internationally. Its products are used in human, veterinary, and pharmaceutical products. Saroja Pharma Industries India Limited was incorporated in 2019 and is based in Mumbai, India.
1. Pharmaceutical Business-This segment offers thionyl chloride and pharmaceutical intermediates, etc. 2. NA-NA 3. NA-NA 4. NA-NA
1. Pharmaceutical Business-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Saroja Pharma Industries India Limited | ₹15 Cr | 9.5 | 9.83% | — | -11.9% |
Listed by market capitalisation. Ratios are shown for context only.
Saroja Pharma Industries India Limited is trading at ₹38.00, with a market capitalisation of ₹15 Cr.
Saroja Pharma Industries India Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Saroja Pharma Industries India Limited has a P/E of 9.5 and a return on equity of 9.83%.
Saroja Pharma Industries India Limited is listed on the NSE under the symbol SAROJA.
Saroja Pharma Industries India Limited's share price is down 11.9% over one year and up 20.8% over three months. Its 52-week range is ₹28.00 to ₹43.25.
Promoters held 73.02% of Saroja Pharma Industries India Limited's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.